Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Investment with representation on the Board of Directors and technical know-how
The Portal BioRRAP will cater to all those seeking regulatory approval for biological research
The plan is to advance innovative therapies to drug-resistant cancers
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
Subscribe To Our Newsletter & Stay Updated